Quotidiano Nazionale logo
la Nazione logo
Quotidiano Nazionale logo
la Nazione logo
20 dic 2021
20 dic 2021

Omicron, Moderna: da gennaio 2022 al via test clinici specifici per il vaccino

Secondo i dati preliminari diffusi dalla società farmaceutica, mezza dose di richiamo Moderna aumenta i livelli di anticorpi contro la variante Omicron di 37 volte e di 83 con dose intera

20 dic 2021
(FILES) This file picture taken on November 18, 2020 shows a syringe and a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. - US biotechnology firm Moderna on January 25, 2021 said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7. (Photo by JOEL SAGET / AFP) / -- IMAGE RESTRICTED TO EDITORIAL USE - STRICTLY NO COMMERCIAL USE --
Vaccino Moderna
(FILES) This file picture taken on November 18, 2020 shows a syringe and a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. - US biotechnology firm Moderna on January 25, 2021 said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7. (Photo by JOEL SAGET / AFP) / -- IMAGE RESTRICTED TO EDITORIAL USE - STRICTLY NO COMMERCIAL USE --
Vaccino Moderna

© Riproduzione riservata

Iscriviti alla newsletter.

Il modo più facile per rimanere sempre aggiornati

Hai già un account?